DK2964215T3 - Blanding af fedtsyrer til anvendelse i behandlingen af inflammatoriske patologier - Google Patents

Blanding af fedtsyrer til anvendelse i behandlingen af inflammatoriske patologier Download PDF

Info

Publication number
DK2964215T3
DK2964215T3 DK14708015T DK14708015T DK2964215T3 DK 2964215 T3 DK2964215 T3 DK 2964215T3 DK 14708015 T DK14708015 T DK 14708015T DK 14708015 T DK14708015 T DK 14708015T DK 2964215 T3 DK2964215 T3 DK 2964215T3
Authority
DK
Denmark
Prior art keywords
mixture
treatment
fat acids
inflammatory pathologies
pathologies
Prior art date
Application number
DK14708015T
Other languages
English (en)
Inventor
Lodovico Burattin
Original Assignee
Again Life Italia Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48227394&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2964215(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Again Life Italia Srl filed Critical Again Life Italia Srl
Application granted granted Critical
Publication of DK2964215T3 publication Critical patent/DK2964215T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
DK14708015T 2013-03-08 2014-03-04 Blanding af fedtsyrer til anvendelse i behandlingen af inflammatoriske patologier DK2964215T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361774796P 2013-03-08 2013-03-08
IT000354A ITMI20130354A1 (it) 2013-03-08 2013-03-08 Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.
PCT/EP2014/054163 WO2014135529A1 (en) 2013-03-08 2014-03-04 Mixture of fatty acids for use in the treatment of inflammatory pathologies

Publications (1)

Publication Number Publication Date
DK2964215T3 true DK2964215T3 (da) 2019-11-11

Family

ID=48227394

Family Applications (2)

Application Number Title Priority Date Filing Date
DK17169929.1T DK3219316T3 (da) 2013-03-08 2014-03-04 Blanding af fedtsyrer (f.a.g., fedtsyregruppe) til anvendelse i behandlingen af inflammatoriske patologier
DK14708015T DK2964215T3 (da) 2013-03-08 2014-03-04 Blanding af fedtsyrer til anvendelse i behandlingen af inflammatoriske patologier

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK17169929.1T DK3219316T3 (da) 2013-03-08 2014-03-04 Blanding af fedtsyrer (f.a.g., fedtsyregruppe) til anvendelse i behandlingen af inflammatoriske patologier

Country Status (18)

Country Link
US (2) US11020365B2 (da)
EP (2) EP3219316B1 (da)
AU (2) AU2014224710B2 (da)
CA (1) CA2904112C (da)
CY (2) CY1122248T1 (da)
DK (2) DK3219316T3 (da)
EA (2) EA036724B1 (da)
ES (2) ES2779851T3 (da)
HR (2) HRP20191963T1 (da)
HU (2) HUE048361T2 (da)
IT (1) ITMI20130354A1 (da)
LT (2) LT3219316T (da)
PL (2) PL3219316T3 (da)
PT (2) PT3219316T (da)
RS (2) RS60023B1 (da)
SI (2) SI2964215T1 (da)
SM (2) SMT201900614T1 (da)
WO (1) WO2014135529A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20130354A1 (it) 2013-03-08 2014-09-09 Again Life Italia Srl Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.
JP7118642B2 (ja) 2014-08-08 2022-08-16 アリ リサーチ ソシエタ ア レスポンサビリタ リミタータ センプリフィカタ 炎症性およびアレルギー性病変の治療に用いるための脂肪酸とパルミトイルエタノールアミドの混合物
AR102008A1 (es) * 2015-09-24 2017-01-25 Brix S R L Ingrediente farmacéutico activo (ifa) oleoso para el tratamiento de afecciones de la piel, composiciones que lo comprenden y su uso para prepararlas
WO2019231281A1 (ko) * 2018-05-31 2019-12-05 재단법인 아산사회복지재단 폐섬유증의 예방 또는 치료를 위한 스테아르산의 용도
EP3586641A1 (en) 2018-06-21 2020-01-01 Nuseed Pty Ltd Dha enriched polyunsaturated fatty acid compositions
EP3586643A1 (en) 2018-06-21 2020-01-01 Nuseed Pty Ltd Dha enriched polyunsaturated fatty acid compositions
KR102204097B1 (ko) * 2019-01-31 2021-01-18 동신대학교 산학협력단 지방산을 유효성분으로 포함하는 천식 예방 또는 치료용 조성물
EP4103145A4 (en) * 2020-02-12 2024-07-03 Retrotope, Inc. DEUTERATED POLYUNSATURATED FATTY ACIDS OR THEIR ESTERS FOR COSMETIC APPLICATIONS
EP4384157A4 (en) * 2021-08-09 2025-06-25 Kentucky Equine Research, Inc. COMPOSITIONS AND METHODS FOR MODULATING EQUINE FATTY ACID PROFILES
CA3231729A1 (en) * 2021-11-24 2023-06-01 Jenivision Inc. Delivery methods for treating brain and central nervous system diseases
CN119385999A (zh) * 2024-11-06 2025-02-07 中国人民解放军军事科学院军事医学研究院 壬二酸在制备防治放射性肺损伤药物中的应用
CN120000629B (zh) * 2025-01-22 2025-12-05 华南师范大学 壬二酸在制备防治脓毒症急性肺损伤药物中的应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993021912A1 (de) * 1992-04-28 1993-11-11 Fresenius Ag Verwendung einer omega-3-fettsäuren enthaltenden emulsion zur herstellung eines parenteral zu verabreichenden arzneimittels zur behandlung von entzündlichen erkrankungen
UY24246A1 (es) * 1995-06-06 1996-06-14 Neutrogena Corp Vehiculos tropicos que contienen acido azelaico solubilizado y estabilizado
EP1175901B1 (en) * 1999-04-15 2006-05-31 Kaneka Corporation Peroxisome activator-responsive receptor agonists
GB9923738D0 (en) 1999-10-07 1999-12-08 Nestle Sa Nutritional composition
DE10161729A1 (de) 2001-12-15 2003-06-18 Mira Ursic Medizinische bzw. pharmazeutische Salbenzubereitung
EP1358872B1 (de) 2002-04-30 2008-03-12 Cognis IP Management GmbH Verwendung von Wirkstoffmischungen mit Azelainsäure und Glycyrrhetinsäure als Anti-Aknemittel
US7612111B2 (en) * 2003-03-20 2009-11-03 Imagenetix, Inc. Esterified fatty acid composition
US20080057552A1 (en) * 2006-08-31 2008-03-06 Inmok Lee Processes for Producing Fats or Oils and Compositions Comprising the Fats or Oils
NZ552238A (en) 2006-12-20 2009-07-31 Seperex Nutritionals Ltd An extract
JP4512881B2 (ja) * 2007-11-27 2010-07-28 築 中島 薬用油脂
MX2010010214A (es) * 2008-03-20 2010-12-21 Virun Inc Derivados de vitamina e y sus usos.
US20090264520A1 (en) 2008-04-21 2009-10-22 Asha Lipid Sciences, Inc. Lipid-containing compositions and methods of use thereof
WO2010049954A1 (en) * 2008-10-31 2010-05-06 Lipid Pharmaceuticals Ehf. Fatty acids for use as a medicament
ES2574136T5 (es) 2009-04-17 2019-08-30 Natac Pharma S L Composiciones ricas en ácidos grasos omega 3 con un bajo contenido en ácido fitánico
EP2796129B1 (en) * 2009-09-07 2015-06-17 Epitech Group S.r.l. Composition containing ultra - micronized palmitoyl - ethanolamide
CA2703532C (en) 2010-05-10 2018-05-01 Eva Turley Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications
DE102010021671A1 (de) 2010-05-27 2011-12-01 Intendis Gmbh Azelainsäurehaltige Formulierung mit Pigmentzusatz
PT2661266T (pt) 2011-01-07 2020-11-30 Anji Pharma Us Llc Terapias com base em ligandos do recetor quimiossensorial
US20120252888A1 (en) * 2011-03-29 2012-10-04 Palupa Medical Ltd. Compositions and Methods for Treating Neurologic Disorders
ITMI20130354A1 (it) * 2013-03-08 2014-09-09 Again Life Italia Srl Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.

Also Published As

Publication number Publication date
HRP20191963T1 (hr) 2020-01-24
AU2018202190A1 (en) 2018-04-26
ES2753257T3 (es) 2020-04-07
HUE046239T2 (hu) 2020-02-28
AU2014224710B2 (en) 2018-04-12
EP2964215B1 (en) 2019-08-21
PT3219316T (pt) 2020-03-27
EA201791885A1 (ru) 2018-01-31
RS60023B1 (sr) 2020-04-30
LT3219316T (lt) 2020-04-10
PL2964215T3 (pl) 2020-03-31
SMT201900614T1 (it) 2020-01-14
HRP20200394T1 (hr) 2020-06-12
HUE048361T2 (hu) 2020-08-28
PT2964215T (pt) 2019-11-12
RS59523B1 (sr) 2019-12-31
US20160015666A1 (en) 2016-01-21
CY1122248T1 (el) 2020-11-25
LT2964215T (lt) 2019-11-25
AU2014224710A1 (en) 2015-09-10
WO2014135529A1 (en) 2014-09-12
CA2904112C (en) 2021-03-23
EP2964215A1 (en) 2016-01-13
ITMI20130354A1 (it) 2014-09-09
SI2964215T1 (sl) 2019-12-31
US11020365B2 (en) 2021-06-01
EA035091B1 (ru) 2020-04-27
CA2904112A1 (en) 2014-09-12
EP3219316A1 (en) 2017-09-20
ES2779851T3 (es) 2020-08-20
DK3219316T3 (da) 2020-03-16
EA036724B1 (ru) 2020-12-11
PL3219316T3 (pl) 2020-06-01
HK1243924A1 (en) 2018-07-27
CY1122783T1 (el) 2021-05-05
EP3219316B1 (en) 2020-02-19
SMT202000115T1 (it) 2020-05-08
EA201591680A1 (ru) 2015-12-30
US20210290578A1 (en) 2021-09-23
SI3219316T1 (sl) 2020-07-31
AU2018202190B2 (en) 2019-05-02

Similar Documents

Publication Publication Date Title
CY2021007I1 (el) Συνθεσεις χρησιμες για τη θεραπεια διαταραχων που σχετιζονται με kit
DK3811943T3 (da) Forbindelse til anvendelse til behandling af øjenlidelser
EP3763364C0 (en) SELF-EMULSIFYING OMEGA-3 FATTY ACID COMPOSITION
DK3054783T3 (da) Sammensætning af mellemkædede fedtsyrer og foder suppleret med samme
EP3520877C0 (en) Grease filter
SI2964215T1 (sl) Mešanica maščobnih kislin za uporabo pri zdravljenju vnetnih patologij
DK3021839T3 (da) Sammensætninger for behandling af fibrose
DK3010895T3 (da) Fremgangsmåde til fremstilling af 4-propargyleret aminobenzoxazinoner
DK3149049T3 (da) Il-22 til anvendelse til behandling af stofskiftesygdomme
DK3083683T3 (da) Sammensætninger og fremgangsmåder til behandling af fedtvævsansamlinger
DK3177281T3 (da) Blanding af fedtsyrer og palmitoylethanolamid til brug i behandlingen af betændelses og allergiske patologier
DK2956010T4 (da) Fedtsammensætning
HRP20181122T1 (hr) Postupak za pripremu jopamidola
DK3044229T3 (da) Peptider til anvendelse i behandlingen af oral mucositis
DK2886108T4 (da) Optimeret farmaceutisk formulering til behandling af inflammatoriske ændringer af øsofagus
PT3016654T (pt) Ácido tauroursodeoxicólico (tudca) para utilização no tratamento de doenças neurodegenerativas
ZA201507724B (en) The treatment of inflammatory disorders
EP2873719A4 (en) GREASE COMPOSITION
DK3041831T3 (da) Alfa-te-saltformer: sammensætninger og anvendelser til behandling af sygdom
FI20150044A7 (fi) Rasvahappokoostumus
DK3369435T3 (da) Sammensætning til behandling af inflammatorisk ledsygdom
HUE042691T2 (hu) Tiazolo-pirimidinon felhasználása gyulladásos bélbetegségek kezeléséhez
ES1079130Y (es) Camilla con aplicacion de masaje automatico
BR302013001555S1 (pt) Configuração aplicada em instrumento para assar peixe
ES1095430Y (es) Camilla para masajes